The protective effect of vasoactive intestinal peptide (VIP) on stress-induced gastric ulceration in rats

Annals of the New York Academy of Sciences

Volumn 865, Issue , 1998, Pages 309-322

  Tunçel, Neş'e ^a   Erkasap, Nilüfer ^a   Şahintürk, Varol ^a   Doǧrukol Ak, Dilek ^b   Tunçel, Muzaffer ^a,b  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

^b ANADOLU UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; IMMOBILIZATION STRESS; INTRAPERITONEAL DRUG ADMINISTRATION; LIPID PEROXIDATION; MALE; MAST CELL DEGRANULATION; NONHUMAN; RAT; STOMACH PROTECTION; STOMACH ULCER; STRESS ULCER;

ANIMALIA;

EID: 0032434070     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb11191.x     Document Type: Conference Paper

References (46)

1. Das, D. & R. K. Banerjee. 1993. Effect of stress on the antioxidant enzymes and gastric ulceration. Molec Cell. Biochem. 125: 115-125.
2. Çoşkun, T., I. Alican, B. Ç. Yegen, T. San, S. Cetnel & H. Kurtel. 1994. Cyclosporin A reduced the severity of cold-restraint induced gastric lesions: Role of leukocytes. Digestion 336: 1-10.
3. Al-Mashhadani, W. M, K. H. Karim, R. I. Al-Taie & H. Al-Zahawi. 1991. Nifedipine versus cimetidine in prevention of stress-induced gastric ulcers in rats. Eur. J. Pharmacol. 192: 117-121.
4. Cho, C. H. & C. W. Ogle. 1989. Paracetamol potentiates stress-induced gastric ulceration in rats. J. Pharm. Pharmacol. 42: 505-507.
5. Ray, A., P. G. Henke & R. M. Sullivan. 1990. Noradrenergic mechanisms in the central amygdalar nucleus and gastric stress ulcer formation in rats. Neurosci. Lett. 110: 331-336.
6. Ray, A., S. Puri, A. K. Chakravarty & P. Sen. 1992. Central histaminergic involvement during stress in rats. Indian J. Exp. Biol. 30: 724-728.
7. 1 in rat stomachs: A possible gastric anti-ulcer mechanism in coldrestraint stressed rats. Pharmacology 44: 177-189.
8. Ogle, C. W. & C. H. Cho. 1989. The protective mechanism of FPL55712 against stress-induced gastric ulceration in rats. Agents & Actions 26: 3-4.
9. 2-receptor activation in stress ulceration in rats. Eur. J. Pharmacol. 55: 23-33.
10. Ogle, C. W. & S. C. G. Hui. 1995. The influence of peripheral or central administration of ondansetron on stress-induced gastric ulceration in rats. Experienta 51: 786-789.
11. Fordtran, S. 1989. Pathogenesis of stress ulcer. In Gastrointestinal Disease. 4th edit. p. 785. W. B. Saunders Company. Philadelphia.
12. 2 receptor: Involvement in gastric ulceration. Life Sci. 18: 339-344.
13. Karmeli, F., R. Eliakim, E. Okon & D. Rachmilewitz. 1991. Gastric mucosal damage by ethanol is mediated by substance P and prevented by ketotifen, a mast cell stabilizer. Gastroenterology 100: 1206-1216.
14. Tabuchi, Y. & Y. Kurebayashi. 1992. Effect of DS-4574, a novel peptidoleukotriene antagonist with mast cell stabilizing action, on gastric lesions and gastric secretion in rats. Jpn. J. Pharmacol. 60: 335-340.
15. Li, T. & X. J. Zhang. 1993. Role of oxygen-derived free radicals in stress-induced gastric ulceration. Acta Physiol. Sin. 45: 286-291.
16. Said, S. I. 1995. Vasoactive intestinal peptide. Airway smooth muscle, peptide receptors, ion channels and signal transduction. Roseburn & M. A. Giembyez, Eds. Birkhjuser Verlag, Basel.
17. Said, S. I. 1986.Vasoactive intestinal peptide. J. Endocrinol Invest. 9: 191-200.
18. Tunçel, N., F. Gürer, E. Aral, K. Uzuner, Y. Aydin & C. Bayçu. 1995. The effect of vasoactive intestinal peptide (VIP) on mast cell invasion/degranulation in testicular interstitium of immobilized + cold stressed and β-endorphin-treated rats. Peptides 17: (5): 817-824.
19. 2 receptor blockers on degranulation. Pharmacology 43: 47-52.
20. Tikiz, H., N. Tunçel, M. Z. Akin & F. Gürer. 1992. The effect of vasoactive intestinal peptide (VIP) and naloxone combination on survival rates exposed to severe hemorrhage. Peptides 13: (1): 83-89.
21. Said, S. I. 1994. VIP and nitric oxide: Physiological co-transmitters with antagonistic roles in inflammation. Biomed. Res. 15 (Suppl. 2): 79-84.
22. Pakbaz, H., H. Berisha, H. D. Foda, A. Absood & S. I. Said. 1994. Vasoactive intestinal peptide (VIP) and related peptides: A new class of anti-inflammatory agents? In International Symposium on Vasoactive Intestinal Peptide Pituitary Adenylate Cyclase Activating Polypeptide and Related Regulatory Peptide. G. Rosselin, Ed.: 597-605. World Scientific. Singapore.
23. Said, S. I. 1996. Vasoactive intestinal peptide and nitric oxide divergent roles in relation to tissue injury. Ann. N.Y. Acad. Sci. 805: 379-388.
24. Akin, M. Z., N. Tunçel, F. Gürer, N. Kural & S. Uslu. 1993. Effect of vasoactive intestinal peptide and naloxone combination on urinary N-acetyl-β-D-glucosaminidase level and kidney histology of rats exposed to severe hemorrhage. Pharmacology 47: 194-199.
25. Uzuner, K., N. Tunçel, Y. Aydin, M. Tunçel, F. Gürer, P. Benli & D. Ak. 1995. The effect of vasoactive intestinal peptide (VIP) on Superoxide dismutase and catalase activities in renal tissues of rats exposed to hemorrhagic ischemia-reperfusion. Peptides 16 (5): 911-915.
26. Tunçel, N., H. Başmak, K. Uzuner, M. Tunçel, G. Altikokka, V. Zaimoǧlu, A. Özer & F. Gürer. 1996. Protection of rat retina from ischemia-reperfusion injury by vasoactive intestinal peptide (VIP): The effect of VIP on lipid peroxidation and antioxidant enzyme activity of retina and choroid. Ann. N.Y. Acad. Sci. 805: 489-497.
27. Tunçel, N., S. Erden, K. Uzuner, G. Altiokka & M. Tunçel. 1997. Ischemic-reperfused rat skeletal muscle: The effect of vasoactive intestinal peptide (VIP) on contractile force, oxygenation and antioxidant enzyme systems. Peptides 18 (2): 269-275.
28. Tunçel, N., Y. Aydin, M. Koşar & M. Tunçel. 1997. The effect of vasoactive intestinal peptide (VIP) on the testicular tissue histamine level of immobilized + cold stressed rats. Peptides 18 (6): 913-915.
29. Kostyuk, A. V. & A. I. Potapovich. 1989. Superoxide-driven oxidation of quercetine and a simple sensitive assay for determination of superoxide dismutase. Biochem. Int. 19: 1117-1134.
30. Glick, D. 1982. Methods of biochemical analysis. In Adaptation of Polarographic Oxygen Sensors for Biochemical Assays, Vol 28. M. A. Lessler, Ed.: 175-199. New York. Wiley-Interscience.
31. Wang, J. & S. M. Lin. 1988. Mixed plant tissue-carbon paste bioelectrode. Anal. Chem. 60: 1545-1548.
32. Rao, N. A. 1990. Role of oxygen free radicals in retinal damage associated with experimental uveitis. Trans. Am. Ophthalmol. Soc. 88: 797-850.
33. Lowry, O. H., N. J. Rosebrought, A. L. Farr & R. J. Randal. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265-275.
34. Berisha, H., H. D. Foda, H. Sakakibara, M. Trotz, H. Pakbaz & S. I. Said. 1990. Vasoactive intestinal peptide (VIP) prevents lung injury due to xanthine/xanthine oxidase. Am. J. Physiol. 259: L151-L155.
35. Misra, R. B. & P. H. Misra. 1990. Vasoactive intestinal peptide (VIP), a singlet oxygen quencher. J. Biol. Chem. 265: 15371-15374
36. Kurosawa, M. & T. Ishizuka. 1993. Inhibitory effects of vasoactive intestinal peptide on superoxide anion formation by N-formyl-methionyl-leucyl-phenylalaline-activated inflammatory cells in vitro. Int. Arch. Allergy Immunol. 100: 28-34.
37. Sakakibara, H., J. Takamatsu & S. I. Said. 1990. Vasoactive intestinal peptide (VIP) inhibits superoxide anion release from rat alveolar macrophages. Am. Rev. Respir. Dis. 141: A645.
38. Whiteside, C. & M. H. Hassan. 1987. Induction and inactivation of catalase and superoxide dismutase of Eschericha coli by ozone. Arch. Biochem. Biophys. 257: 464-471.
39. Goossens, J., J. V. Reempts & J. P. Van Waume. 1987. Cytoprotective effects of disodium cromoglycate on rat stomach mucosa. Br. J. Pharmac. 91: 165-169.
40. Galli, S. 1990. Biology of disease. Lab. Invest. 62: 5-25.
41. Pearce, F. L. 1986. On the heterogeneity of mast cells. Pharmacology 32: 61-71.
42. Derek, M., M. McKay & J. Bienenstock. 1994. The interaction between mast cells and nerves in the gastrointestinal tract. Immunol. Today. 15: 11.
43. Aiuti, F., C. Carini & R. Paganelli. 1989. Report on the XIII ICACI Montreux, Switzerland on 17-23 October 1988. Immunol. Today 10: 71-73.
44. Cutz, E., W. Chan, N. S. Track, A. Goth. & S. I. Said. 1978. Release of vasoactive intestinal polypeptide in mast cells by histamine liberator. Nature 275: 661-662.
45. Trabucchi, E., E. Radaelli, M. Marazzi, D. Foschi, M. Musazzi & A. M. Veronesi. 1988. The role of mast cells in wound healing. Int. J. Tiss. Reac. X (6): 367-372.
46. Andre, F., J. Gillon, C. Andre & S. Fournier. 1983. Role of mast cell mediators in pathogenesis of anaphylactic gastric ulcer. Digestion 28: 108-113.